primary myelofibrosis

Explore academic connections and research related to this keyword

233
Views
14
Total Connections
Search More Keywords

Related Articles & Bibliographies

1
t(15; 17) associated with primary myelofibrosis: a case report of an unusual clinical presentation and diagnostic dilemma.
Nadiminti, Kalyan;Silverman, Margarida;Bhagavathi, Sharathkumar;Vikas, Praveen;
2019 OncoTargets and therapy DOI: 10.2147/OTT.S208290 324 views
2
Integrating clinical, morphological, and molecular data to assess prognosis in patients with primary myelofibrosis at diagnosis: A practical approach.
Iurlo, Alessandra;Elli, Elena Maria;Palandri, Francesca;Cattaneo, Daniele;Bossi, Anna;Cortinovis, Iv...
2019 hematological oncology DOI: 10.1002/hon.2658 233 views
3
Adding hydroxyurea in combination with ruxolitinib improves clinical responses in hyperproliferative forms of myelofibrosis.
Pugliese, Novella;Giordano, Claudia;Nappi, Davide;Luciano, Luigiana;Cerchione, Claudio;Annunziata, M...
2019 Cancer medicine DOI: 10.1002/cam4.2147 241 views
4
Comparison of Outcomes of Allogeneic Transplantation for Primary Myelofibrosis among Hematopoietic Stem Cell Source Groups.
Murata, Makoto;Takenaka, Katsuto;Uchida, Naoyuki;Ozawa, Yukiyasu;Ohashi, Kazuteru;Kim, Sung-Won;Ikeg...
2019 biology of blood and marrow transplantation : jour... DOI: S1083-8791(19)30144-... 220 views
5
Recurrent ischaemic cerebrovascular events as presenting manifestations of myeloproliferative neoplasms.
Stefanou, M I;Richter, H;Härtig, F;Wang, Y;Örgel, A;Bender, B;Mengel, A;Ziemann, U;Poli, S;
2019 European journal of neurology DOI: 10.1111/ene.13907 289 views
6
Do All Patients With Polycythemia Vera or Essential Thrombocythemia Need Cytoreduction?
Sankar, Kamya;Stein, Brady L;
2018 journal of the national comprehensive cancer netwo... DOI: 10.6004/jnccn.2018.7... 280 views
7
ruxolitinib treatment in a patient with primary myelofibrosis resistant to conventional therapies and splenectomy: a case report
;Meltem Aylı;Muhit Özcan;Güldane Cengiz Seval
2015 proceedings of the international conference on iot... DOI: 10.4274/tjh.2013.033... 161 views
8
the european clinical, molecular, and pathological (ecmp) criteria and the 2007/2008 revisions of the world health organization for the diagnosis, classification, and staging of prefibrotic myeloproliferative neoplasms carrying the jak2v617f mutation
;Jan Jacques Michiels;Fibo Ten Kate;King H. Lam;Wilfried Schroyens;Zwi Berneman;Hendrik De Raeve
2014 proceedings of the international conference on iot... DOI: 10.4274/Tjh.2013.013... 408 views

Related Research Groups

No Research Groups Found

No research groups are currently associated with this keyword.

Explore Related Keywords

fish case report atypical t(15;17) cytogenetics prognosis bone marrow fibrosis driver mutations risk categories ruxolitinib hydroxyurea janus kinase (jak) inhibitors allogeneic transplantation unrelated donor stroke myeloproliferative neoplasms essential thrombocythemia polycythemia vera jak2 mutation myeloproliferative neoplasm